Secondary Logo

Journal Logo

Correspondence

Mask on Followed by Gloves on: Do We Have a Choice?

Author Information
International Journal of Dermatology and Venereology: September 2021 - Volume 4 - Issue 3 - p 195-196
doi: 10.1097/JD9.0000000000000138
  • Open

Dear Editor:

On 23 July 2020, China reported a case of domestically transmitted COVID-19 in a 58-year-old man who worked for a seafood-processing company. The patient was confirmed to be SARS-CoV-2–positive. The patient had no contact history; however, previously published data indicated that some fish had tested positive for SARS-CoV-2, and we therefore considered that SARS-CoV-2 might have been transmitted to this patient through such contact. Meanwhile, the Centers for Disease Control and Prevention reminded the population that citizens should wear gloves when touching frozen or chilled food. Wearing a mask and gloves thereafter seemed to become the “new normal” in life. Although masks appeared to be an effective way to stop the spread of COVID-19, healthcare workers facing higher intensities of SARS-CoV-2 were becoming infected even with their masks on.1 Thus, a question arises: If we must wear gloves, why should we? Could there be other protection method instead of gloves?

The goal of mask-wearing policies is to prevent the transmission of SARS-CoV-2 via the respiratory tract. Are glove-wearing policies thus implemented to prevent the transmission of SARS-CoV-2 via the skin? Wearing a mask only reduces, but does not eliminate, the risk of infection by SARS-CoV-22; the virus might also be transmitted in other ways. Could the skin be one of these transmission routes? A well-known line in Chinese medicine is that “the skin is the twin of the lung.” This saying might represent ancient wisdom indicating that the skin could be a bridge of SARS-CoV-2 transmission.

There is evidence supporting the necessity of wearing gloves. Angiotensin-converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2 and is essential for viral entry into cells. Xue et al.3 reported that ACE2 can be expressed in the skin. This gives the virus an opportunity to enter cells. Notably, however, ACE2 is mainly expressed in the basal layer of the skin, which is located below multiple layers of strongly connected keratinocytes.4-5 This suggests a limited possibility that SARS-CoV-2 can travel through a well-constructed skin barrier. However, what if the skin barrier is compromised? Deterioration of the skin barrier is observed in many patients with inflammatory skin conditions. Could an inflammatory skin condition with deterioration of the barrier function be a specific circumstance allowing SARS-CoV-2 to be transmitted via the skin? Atopic dermatitis is a representative example of an inflammatory skin disease associated with a deteriorated barrier function,6 and elevated levels of ACE2 are detected in the lesions of patients with this disease.7 In our own research, we have similarly found elevated ACE2 levels in the skin lesions of patients with psoriasis. Another factor associated with entry of SARS-CoV-2 into cells is transmembrane serine protease 2 (TMPRSS2), which primes the viral spike proteins to allow viral entry into the target cell. The mRNA level of TMPRSS2 was elevated in mouse models of inflammatory skin conditions with deteriorated skin barrier functions. Additionally, after application of fluorescein isothiocyanate-conjugated SARS-CoV-2 spike protein to the skin of mice, spike protein deposition was detected in the mice with deteriorated skin barrier function and inflammatory skin conditions but was hardly detected in the mice with normal skin.

All of the above results suggest that an inflammatory skin condition with barrier dysfunction may be a specific circumstance that allows SARS-CoV-2 to be transmitted through the skin. However, these data are not solid enough8; they do not actually verify whether that SARS-CoV-2 can be transmitted through the skin. Fortunately, however, the development of in vivo imaging systems9 and humanized ACE2 mouse models have provided the opportunity to definitively prove whether SARS-CoV-2 can be transmitted through the skin. Thus, we encourage researchers to further examine the possible routes of SARS-CoV-2 transmission. Being a backup of gloves-wearing force or seeking for other protection instead of gloves? What is your choice?

Yours Qian-Nan Xu and Jie Zheng

Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China.

Corresponding author: E-mail: [email protected].

References

[1]. Chen T, Li G, Liu H, et al. Clinical characteristics of 132 healthcare worker cases with COVID-19: A retrospective study from a single center in Wuhan, China. J Med Virol 2021;93(3):1631–1638. doi: 10.1002/jmv.26511.
[2]. Javid B, Weekes MP, Matheson NJ. COVID-19: should the public wear face masks. BMJ 2020;369:m1442. doi: 10.1136/bmj.m1442.
[3]. Xue X, Mi Z, Wang Z, et al. High expression of ACE2 on Keratinocytes reveals skin as a potential target for SARS-CoV-2. J Invest Dermatol 2020;141(1):206–209. e1. doi:10.1016/j.jid.2020.05.087.
[4]. Wong R, Geyer S, Weninger W, et al. The dynamic anatomy and patterning of skin. Exp Dermatol 2016;25(2):92–98. doi:10.1111/exd.12832.
[5]. Wang JN, Li M. The immune function of keratinocytes in anti-pathogen infection in the skin. Int J Dermatol Venereol 2020;3(4):231–238. doi:10.1097/JD9.0000000000000094.
[6]. Weidinger S, Novak N. Atopic dermatitis. Lancet 2016;387(10023):1109–1122. doi:10.1016/S0140-6736(15)00149-X.
[7]. Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020;75(11):2829–2845. doi:10.1111/all.14429.
[8]. Thorp HH. Seeing is believing. Science 2019;366(6472):1423. doi:10.1126/science.aba5359.
[9]. Wang J, Hossain M, Thanabalasuriar A, et al. Visualizing the function and fate of neutrophils in sterile injury and repair. Science 2017;358(6359):111–116. doi:10.1126/science.aam9690.
Copyright © 2021 Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences, and Chinese Medical Association, published by Wolters Kluwer, Inc.